Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Credit Suisse Upgrades Esperion Therapeutics to Outperform


Benzinga | Nov 10, 2020 07:33AM EST

Credit Suisse Upgrades Esperion Therapeutics to Outperform

Credit Suisse upgrades Esperion Therapeutics (NASDAQ:ESPR) from Neutral to Outperform.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC